Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gauging the Risks of Financing Convergence Start-Ups

Nov 01 2005

• By Chris Morrison

Related Content

Angiotech: Specialty Pharma in the Device World

Sep 01 2004

Pfizer/Angiosyn: Building Biotechs for Device-style Early M&A

Feb 01 2005

The New Math of Drug-Device Convergence

Apr 01 2005

Celtic Pharma Sees a Role for Private Equity in Biotech

Nov 01 2005

Corgentech/BMS: Finding Specialty Appeal in a Drug/Device Combo

Nov 01 2003

FoxHollow/Merck R&D Deal: The Value of Plaque

Oct 01 2005

TyRx Pharma Inc.

Sep 01 2005

Convergence: What's Next at the Nexus?

Feb 01 2005

Related Companies

Boston Scientific Corporation

Angiotech Pharmaceuticals, Inc.

Abbott

Medtronic plc

Medtronic plc

Johnson & Johnson

Abbott

Alnylam Pharmaceuticals Inc.

Zalicus Inc.

Plus Therapeutics, Inc.

Olympus Corporation

Sanofi Genzyme

Medtronic plc

Osiris Therapeutics, Inc.

Bristol Myers Squibb Company

Anesiva, Inc.

Merck & Co., Inc.

Medtronic plc

Additional Topics

Strategy Business Strategies Platform Technologies BioPharmaceutical Medical Device Combination Products

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window